Grants and Contributions
About this information
In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.
The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.
Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.
$227,923.00
Dec 1, 2021
Individual or sole proprietorship
Op. Gr: Emer. COVID Res. Gaps/Prior- Dif. Impacts on Hist. Excl/Underserved Pops
163290
Accelerate the availability and use of high-quality and real-time evidence and/or solutions to support Canada’s ongoing response to the pandemic in order to better prevent, detect, treat and manage COVID-19; AND
b. Generate evidence related to one or more marginalized population(s), including for instance: Black and other communities marginalized by race; First Nations, Inuit, Métis and Urban Indigenous Peoples; communities historically excluded from research; those experiencing health inequity; persons with disabilities and individuals across diverse health status (e.g. high risk populations, individuals with comorbid conditions); those experiencing gendered impacts of the pandemic; and those in life stages that have been underrepresented in research (e.g. pregnant people, children, older adults).
$143,428.00
Dec 1, 2021
Individual or sole proprietorship
Op. Gr: Emer. COVID Res. Gaps/Prior- Dif. Impacts on Hist. Excl/Underserved Pops
163295
Accelerate the availability and use of high-quality and real-time evidence and/or solutions to support Canada’s ongoing response to the pandemic in order to better prevent, detect, treat and manage COVID-19; AND
b. Generate evidence related to one or more marginalized population(s), including for instance: Black and other communities marginalized by race; First Nations, Inuit, Métis and Urban Indigenous Peoples; communities historically excluded from research; those experiencing health inequity; persons with disabilities and individuals across diverse health status (e.g. high risk populations, individuals with comorbid conditions); those experiencing gendered impacts of the pandemic; and those in life stages that have been underrepresented in research (e.g. pregnant people, children, older adults).
$497,000.00
Dec 1, 2021
Individual or sole proprietorship
Op. Gr.:Emerging COVID-19 Res. Gaps & Priorities - HIV and SARS-CoV-2
163304
Accelerate the availability and use of high-quality and real-time evidence and/or solutions to support Canada’s ongoing response to the pandemic in order to better prevent, detect, treat and manage COVID-19; AND
b. Generate evidence related to one or more marginalized population(s), including for instance: Black and other communities marginalized by race; First Nations, Inuit, Métis and Urban Indigenous Peoples; communities historically excluded from research; those experiencing health inequity; persons with disabilities and individuals across diverse health status (e.g. high risk populations, individuals with comorbid conditions); those experiencing gendered impacts of the pandemic; and those in life stages that have been underrepresented in research (e.g. pregnant people, children, older adults).
$500,000.00
Dec 1, 2021
Individual or sole proprietorship
Op. Gr.:Emerging COVID-19 Res. Gaps & Priorities - HIV and SARS-CoV-2
163307
Accelerate the availability and use of high-quality and real-time evidence and/or solutions to support Canada’s ongoing response to the pandemic in order to better prevent, detect, treat and manage COVID-19; AND
b. Generate evidence related to one or more marginalized population(s), including for instance: Black and other communities marginalized by race; First Nations, Inuit, Métis and Urban Indigenous Peoples; communities historically excluded from research; those experiencing health inequity; persons with disabilities and individuals across diverse health status (e.g. high risk populations, individuals with comorbid conditions); those experiencing gendered impacts of the pandemic; and those in life stages that have been underrepresented in research (e.g. pregnant people, children, older adults).
$443,448.00
Dec 1, 2021
Individual or sole proprietorship
Op. Gr: Emer. COVID Res/Gps/Prior- Sup. Srv/Rehab, Strat for Hist.
163309
Accelerate the availability and use of high-quality and real-time evidence and/or solutions to support Canada’s ongoing response to the pandemic in order to better prevent, detect, treat and manage COVID-19; AND
b. Generate evidence related to one or more marginalized population(s), including for instance: Black and other communities marginalized by race; First Nations, Inuit, Métis and Urban Indigenous Peoples; communities historically excluded from research; those experiencing health inequity; persons with disabilities and individuals across diverse health status (e.g. high risk populations, individuals with comorbid conditions); those experiencing gendered impacts of the pandemic; and those in life stages that have been underrepresented in research (e.g. pregnant people, children, older adults).
$499,616.00
Dec 1, 2021
Individual or sole proprietorship
Op. Gr.:Emerg. COVID-19 Res. Gaps & Priorities- Health care systems and services
163311
Accelerate the availability and use of high-quality and real-time evidence and/or solutions to support Canada’s ongoing response to the pandemic in order to better prevent, detect, treat and manage COVID-19; AND
b. Generate evidence related to one or more marginalized population(s), including for instance: Black and other communities marginalized by race; First Nations, Inuit, Métis and Urban Indigenous Peoples; communities historically excluded from research; those experiencing health inequity; persons with disabilities and individuals across diverse health status (e.g. high risk populations, individuals with comorbid conditions); those experiencing gendered impacts of the pandemic; and those in life stages that have been underrepresented in research (e.g. pregnant people, children, older adults).
$308,904.00
Dec 1, 2021
Individual or sole proprietorship
Op. Gr.:Emerg. COVID-19 Res. Gaps & Priorities- Health care systems and services
163314
Accelerate the availability and use of high-quality and real-time evidence and/or solutions to support Canada’s ongoing response to the pandemic in order to better prevent, detect, treat and manage COVID-19; AND
b. Generate evidence related to one or more marginalized population(s), including for instance: Black and other communities marginalized by race; First Nations, Inuit, Métis and Urban Indigenous Peoples; communities historically excluded from research; those experiencing health inequity; persons with disabilities and individuals across diverse health status (e.g. high risk populations, individuals with comorbid conditions); those experiencing gendered impacts of the pandemic; and those in life stages that have been underrepresented in research (e.g. pregnant people, children, older adults).
$357,769.00
Dec 1, 2021
Individual or sole proprietorship
Op. Gr:Emerg. COVID Res. Gaps/Priorities- Social/Behavioural Science Approaches
163323
Accelerate the availability and use of high-quality and real-time evidence and/or solutions to support Canada’s ongoing response to the pandemic in order to better prevent, detect, treat and manage COVID-19; AND
b. Generate evidence related to one or more marginalized population(s), including for instance: Black and other communities marginalized by race; First Nations, Inuit, Métis and Urban Indigenous Peoples; communities historically excluded from research; those experiencing health inequity; persons with disabilities and individuals across diverse health status (e.g. high risk populations, individuals with comorbid conditions); those experiencing gendered impacts of the pandemic; and those in life stages that have been underrepresented in research (e.g. pregnant people, children, older adults).
$475,940.00
Dec 1, 2021
Individual or sole proprietorship
Op. Gr.:Emerging COVID-19 Res. Gaps & Priorities (July 2021) - Immune Responses
163330
Accelerate the availability and use of high-quality and real-time evidence and/or solutions to support Canada’s ongoing response to the pandemic in order to better prevent, detect, treat and manage COVID-19; AND
b. Generate evidence related to one or more marginalized population(s), including for instance: Black and other communities marginalized by race; First Nations, Inuit, Métis and Urban Indigenous Peoples; communities historically excluded from research; those experiencing health inequity; persons with disabilities and individuals across diverse health status (e.g. high risk populations, individuals with comorbid conditions); those experiencing gendered impacts of the pandemic; and those in life stages that have been underrepresented in research (e.g. pregnant people, children, older adults).
$216,391.00
Dec 1, 2021
Individual or sole proprietorship
Op. Gr.: Emer. COVID-19 Res. Gaps & Priorities July/21 - Structural Inequalities
163276
Accelerate the availability and use of high-quality and real-time evidence and/or solutions to support Canada’s ongoing response to the pandemic in order to better prevent, detect, treat and manage COVID-19; AND
b. Generate evidence related to one or more marginalized population(s), including for instance: Black and other communities marginalized by race; First Nations, Inuit, Métis and Urban Indigenous Peoples; communities historically excluded from research; those experiencing health inequity; persons with disabilities and individuals across diverse health status (e.g. high risk populations, individuals with comorbid conditions); those experiencing gendered impacts of the pandemic; and those in life stages that have been underrepresented in research (e.g. pregnant people, children, older adults).